MBX Biosciences Inc’s filing revealed that its Director GORDON CARL L acquired Company’s shares for reported $1.55 million on Feb 18 ’25. In the deal valued at $10.84 per share,143,170 shares were bought. As a result of this transaction, GORDON CARL L now holds 3,255,000 shares worth roughly $28.81 million.
Then, GORDON CARL L bought 47,502 shares, generating $468,793 in total proceeds. Upon buying the shares at $9.87, the Director now owns 3,205,930 shares.
Before that, ORBIMED ADVISORS LLC bought 143,170 shares. MBX Biosciences Inc shares valued at $1,551,963 were divested by the Director at a price of $10.84 per share. As a result of the transaction, ORBIMED ADVISORS LLC now holds 3,255,000 shares, worth roughly $28.81 million.
Stifel initiated its MBX Biosciences Inc [MBX] rating to a Buy in a research note published on October 08, 2024; the price target was $40. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in early October with a ‘”an Overweight”‘ rating. Jefferies began covering MBX with “Buy” recommendation on October 08, 2024. Guggenheim started covering the stock on October 08, 2024. It rated MBX as “a Buy”.
Price Performance Review of MBX
On Monday, MBX Biosciences Inc [NASDAQ:MBX] saw its stock jump 1.72% to $8.85. Over the last five days, the stock has lost -1.45%. MBX Biosciences Inc shares have fallen nearly -51.98% since the year began.
Levels Of Support And Resistance For MBX Stock
The 24-hour chart illustrates a support level at 8.48, which if violated will result in even more drops to 8.12. On the upside, there is a resistance level at 9.45. A further resistance level may holdings at 10.05. The Relative Strength Index (RSI) on the 14-day chart is 39.88, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.42%. Stochastics %K at 6.37% indicates the stock is a buying.
How much short interest is there in MBX Biosciences Inc?
A steep rise in short interest was recorded in MBX Biosciences Inc stocks on 2025-02-28, growing by 1.31 million shares to a total of 4.11 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 2.8 million shares. There was a rise of 31.87%, which implies that there is a positive sentiment for the stock.
